BayMedica, Inc. provides a scalable biosynthesis platform for the production of natural and novel cannabinoids. InMed Pharmaceuticals and BayMedica announced a partnership in November of 2020 to integrate the two's biosynthesis technology for better results.
Loading Documents... |